Structure Therapeutics Inc. American Depositary Shares
$34.71
-$0.39 (-1.11%)
$34.41Day Range$35.63
Key Statistics
Market Cap
$2.50B
Shares Outstanding
71.3M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Feb 3, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$35.04
Day High
$35.63
Day Low
$34.41
Volume
596.7K
VWAP
$34.70
Prev Close
$35.10
Transactions
--
Acc. Volume
--
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
PHARMACEUTICAL PREPARATIONSSIC 2834281 employees601 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO, CA, 94080(650) 457-1978IPO Feb 3, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001888886
- Composite FIGI
- BBG01CBVHLW1
- Share Class FIGI
- BBG01CBVHMQ6
- Ticker Root
- GPCR
- SIC Code
- 2834
About Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock
Structure Therapeutics Inc. American Depositary Shares (GPCR) closed the 2026-09-18 session at $34.71, down 1.11% versus the previous close (-0.39). The stock opened at $35.04 and traded between $34.41 and $35.63 during that session. Session trading volume was 597K shares. The volume-weighted average price (VWAP) is $34.70.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Structure Therapeutics Inc. American Depositary Shares has a market capitalization of $2.50 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GPCR is listed on the XNAS exchange. The company employs approximately 281 people. Structure Therapeutics Inc. American Depositary Shares is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2023-02-03.
On this page you can find market GPCR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.